Tiziana Life Sciences (TLSA) Current Assets (2017 - 2025)

Tiziana Life Sciences (TLSA) has reported Current Assets for 9 consecutive years, with $8.6 million the latest figure, recorded in Q4 2025.

• Quarterly Current Assets rose 13.91% year-over-year to $8.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.6 million (up 13.91% YoY) and the FY2025 annual result came in at $8.6 million, up 13.91% from the prior year.
• Current Assets slipped to $8.6 million in Q4 2025 per TLSA's latest filing, from $12.7 million in the prior quarter.
• Over the last five years, Current Assets for TLSA reached as high as $57.2 million in Q2 2021 and fell as low as $7.3 million in Q4 2023.
• A 5-year average of $22.1 million and a median of $13.9 million in 2023 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2021 — Current Assets soared 362.03% — and 2023, when it plunged 69.78%.
• Year by year, Current Assets stood at $48.7 million in 2021, then tumbled by 50.12% to $24.3 million in 2022, then tumbled by 69.78% to $7.3 million in 2023, then climbed by 2.33% to $7.5 million in 2024, then climbed by 13.91% to $8.6 million in 2025.
• According to Business Quant data, Current Assets over the past three periods registered $8.6 million, $12.7 million, and $7.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.